晚期前列腺癌中的肿瘤细胞表面靶向
Targeting the tumour cell surface in advanced prostate cancer.
前列腺癌仍是重大的健康挑战,全球男性每年因此死亡超过 375,000 例。
67.0分
★★★☆☆
ALL SOURCES
Targeting the tumour cell surface in advanced prostate cancer.
前列腺癌仍是重大的健康挑战,全球男性每年因此死亡超过 375,000 例。
Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth.
转移性去势抵抗性前列腺癌(mCRPC)在很大程度上对免疫治疗耐药。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。